BT474 cells also carry physiologic levels of ErbB1 and ErbB3 and low levels of ErbB4 [16], providing them a suitable model system for investigating the impact of ErbB signalling on tumour cell growth and ErbB2-targeted anti-tumour strategies [17]. The gene discussed is EGFR; the disease is neoplasm.